Food Texturizers Market to Reach $11.8 Billion by 2018
A new market report forecasts the Asia-Pacific region to experience the fastest market growth.
According to new report on the market for food texturizers (ingredients that are added to processed foods to enhance stability and palatability), world demand will swell to $11.8 billion by 2018 (+5% CAGR). According to the report from MarketsandMarkets (Dallas), demand will be driven by increased consumer demand for convenience foods such as baked goods, confectionery, and dairy foods.
The report listed North America (the U.S. specifically) as the current most geographically dominant market in terms of demand, with Europe and Asia-Pacific ranking second and third. Asia-Pacific was tapped to enjoy the fastest market growth thanks to its flourishing economy, followed closely by the Rest of the World (all markets not North America, Europe or Asia-Pacific).
Innovations in customizable texturizing ingredients and ingredient blends are also encouraging the category’s growth. The top texturizers in the category are gelling agents and emulsifying agents, respectively. The largest two global application markets are meat and poultry products and bakery and confectionery products.
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
